Our service for you
We at RBP are here to help you!
Explore our comprehensive service section and our RBP distribution partners worldwide. If you would like more information or to contact us directly, we are here to help.
Mono-Material Blister Packs: The Next Generation of Pharmaceutical Packaging
Introduction
As sustainability requirements increase across the pharmaceutical industry, packaging developers are exploring new ways to improve the recyclability of blister packs.
One promising approach is the development of mono-material blister packaging. Unlike traditional blister packs that combine several materials, mono-material blisters aim to use a single polymer structure. This concept simplifies recycling and can make pharmaceutical packaging more compatible with existing material recovery systems.
The Concept of Mono-Material Blisters
Traditional blister packaging relies on composite structures such as plastic combined with aluminium. Mono-material blister designs, by contrast, attempt to build the blister structure using a single polymer material or compatible polymer layers. The goal is to create packaging that can enter established recycling streams without complex material separation. Examples of materials currently being explored include:
- high-barrier PET structures
- polypropylene blister materials
- recyclable polymer barrier solutions.
These materials are designed to provide protection for pharmaceutical products while also enabling more efficient recycling.
The Technical Challenge
Developing mono-material blister packaging is not a simple task. Pharmaceutical packaging must meet strict regulatory requirements related to product stability, barrier performance and patient safety. New blister materials therefore need to demonstrate that they can provide sufficient protection against:
- moisture
- oxygen
- environmental contamination.
Extensive testing is required before such materials can be approved for pharmaceutical use.
Progress and Industry Interest
Despite these challenges, interest in mono-material blister systems is growing. Packaging manufacturers and pharmaceutical companies are investing in research to develop recyclable blister structures that maintain the high performance required for pharmaceutical applications. If successful, these innovations could significantly improve the sustainability profile of pharmaceutical packaging.
The Remaining Challenge
However, even recyclable blister packaging must still be processed correctly once it enters pharmaceutical waste streams. Tablets and capsules must be separated from the packaging before material recovery processes can begin. This step introduces a new technological requirement.
Transition
👉 In the next episode:
How deblistering technologies enable the separation of tablets and blister materials.